Found: 15
Select item for more details and to access through your institution.
Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease.
- Published in:
- Molecular Cancer, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-4598-13-69
- By:
- Publication type:
- Article
Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease.
- Published in:
- Molecular Cancer, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-4598-13-69
- By:
- Publication type:
- Article
Synergistic effect of gefitinib and rofecoxib in mesothelioma cells.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 1, doi. 10.1186/1476-4598-9-27
- By:
- Publication type:
- Article
The effect of CELLFOOD TM on radiotherapy or combined chemoradiotherapy: preclinical evidence.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919878347
- By:
- Publication type:
- Article
Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
CELLFOOD™ induces apoptosis in human mesothelioma and colorectal cancer cells by modulating p53, c-myc and pAkt signaling pathways.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2014, v. 33, n. 1, p. 1, doi. 10.1186/1756-9966-33-24
- By:
- Publication type:
- Article
Metabolism modifications and apoptosis induction after Cellfood administration to leukemia cell lines.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2013, v. 32, n. 1, p. 1, doi. 10.1186/1756-9966-32-63
- By:
- Publication type:
- Article
Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability.
- Published in:
- Journal of Translational Medicine, 2008, v. 6, p. 1, doi. 10.1186/1479-5876-6-27
- By:
- Publication type:
- Article
Amprenavir inhibits the migration in human hepatocarcinoma cell and the growth of xenografts.
- Published in:
- Journal of Cellular Physiology, 2013, v. 228, n. 3, p. 640, doi. 10.1002/jcp.24173
- By:
- Publication type:
- Article
Correction: Identification of novel COX-2 / CYP19A1 axis involved in the mesothelioma pathogenesis opens new therapeutic opportunities.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Expression of the Embryonic Lethal Abnormal Vision-like Protein HuR in Human Mesothelioma: Association With Cyclooxygenase-2 and Prognosis.
- Published in:
- Cancer (0008543X), 2008, v. 113, n. 10, p. 2761, doi. 10.1002/cncr.23904
- By:
- Publication type:
- Article
Correction: CELLFOOD™ induces apoptosis in human mesothelioma and colorectal cancer cells by modulating p53, c-myc and pAkt signaling pathways.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Identification of novel COX-2 / CYP19A1 axis involved in the mesothelioma pathogenesis opens new therapeutic opportunities.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02050-1
- By:
- Publication type:
- Article